万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>药物学

Journal of Asthma(研究方向:过敏) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Journal of Asthma(月刊),创刊于1981年,出版国家为美国。Journal of Asthma刊登哮喘管理,关键和长期护理,预防措施,环境咨询和患者教育等临床研究。期刊从以下角度讨论哮喘:临床免疫学、过敏、肺生理学、心理学、药理、其他与哮喘有关的临床健康趋势,本期刊使用双盲同行评议。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.tandfonline.com/loi/ijas20

3、期刊投稿:

https://mc.manuscriptcentral.com/ljas

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017427日星期四

                       

 

Author Guidelines

 

Submission of Manuscripts:

 

Manuscripts must be submitted through the journal’s website . Paper manuscript submissions are not accepted. Full-length papers comprise the major part of each issue. Mini- reviews are accepted for publication only if they have been invited by the Editors. Authors who would like to submit a mini-review on a topic in which they have expertise are asked to communicate their interest to the Editors.

 

It is the responsibility of the authors to ensure that their papers are in correct English, both grammatically and stylistically, before submission. Papers with substantial defects in English will be returned without review.

 

Informa Healthcare adheres to the Code of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). As per these guidelines, failure to adhere to the conditions outlined within will result in the editor and Informa Healthcare publishing an appropriate correction, a statement of retraction, or enacting a withdrawal of the article.

 

Rapid Publication:

 

Publication is driven entirely by editorial considerations and independent authoritative peer review. As part of the journal’s responsive approach, we would offer a prioritised mode of rapid publication alongside our standard mode.

 

FastTrack: This offers the most highly prioritised service, with a submission to online publication timeline of 3–5 weeks (subject to 1–2 week author revision following initial peer-review and prompt turnaround of proofs). There is a publication support fee for this, based on a charge of $850/€625/£550 per published page. This charge supports the ultra-swift processing of material and 20 downloads of the article via e- access tokens.

 

StandardTrack: This standard service provides submission to online publication in up to 20 weeks; there are no publication support fees charged for this mode.

 

We welcome contact with the Editorial Offices preceding formal submission and particularly encourage prior contact for FastTrack submissions where a particular publication deadline is desired.

 

If you are would like to pay for the FastTrack service, please e-mail Managing Editor Patrice Galimore within 24 hours of submitting your manuscript.

 

Manuscript Preparation

 

The following article types are considered for publication in Journal of Asthma:

 

    Original articles

    Review articles

    Letters to the editor

    Commentaries

    Book reviews

    Case Studies

 

All Submissions should have a maximum of 12 keywords, 60 references, and a combined total of 8 tables and/or figures. Text should not exceed 4,000 words.

 

Manuscripts in excess of 5,000 words will be considered at the Editor's discretion.

 

Note: Journal of Asthma will not consider for publication manuscripts on research funded by tobacco companies

 

Manuscripts are preferred in double-spaced Microsoft Word format (.doc files). Tables and figures should not appear in the main text – specific instructions for their submission are given below. References should follow the NLM style (see References section for examples). Only English-language manuscripts are considered.

 

Manuscripts should be compiled in the following order: Title page containing running head and keywords; Main text; Acknowledgments (if applicable); Declaration of Interest statement (mandatory); References; Appendices (if applicable); Tables with captions; Figures; and Figure captions.

 

Title Page

 

Provide a title page with your submission, including in it the manuscript title and names and affiliations of all authors. Clearly designate the corresponding author and his/her full contact information, including phone number and email address. Please include the running head of no more than 50 characters. At least 5-7 keywords that are not in the title or the journal name should also be included on the title page. These keywords will assist indexers in cross-indexing the article, and should therefore be included in the abstract.

 

Main Text

 

All articles should start with an unstructured abstract of no more than 250 words. The Abstract must be divided up under the following headings: Objective, Methods, Results and Conclusions.

 

    Original articles

The body of original articles should include the following distinct sections: Introduction: This section should state the background to and purpose of the study.

Methods: Please identify the methods, mechanisms, and procedures in sufficient detail to allow others to reproduce the results, and describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Journal of Asthma requires that studies involving animals/humans be approved by an institutional review board, in accordance with approved published guidelines, prior to actually performing the research and publishing the data. This approval should be explicitly stated in the methods section. Please also see the section on Ethics and Consent and Statistical Notes.

Results: Please present your results concisely and accurately. For studies reporting clinical trials, include the sample size of each data point, with p-values and confidence intervals quoted for both significant and non-significant findings.

Discussion: This should include implications of the findings and their limitations, with reference to other relevant studies and the possibilities these suggest for future research.

Conclusions/key findings: This section should be distinct from the Discussion section and should concisely summarize the clinical implications or key research findings.

 

     Review Articles

The body of a review article should be a comprehensive, scholarly evidence-based review of the literature, accompanied by critical analysis and leading to reasonable conclusions. Wherever appropriate, details of the literature search methodology should be provided, i.e. the databases searched, the search terms and inclusive dates, and any selectivity criteria imposed. Wherever possible, use primary resources, avoiding “Data on File”, “Poster” or other unpublished references.

 

Review articles address a specific question or issue that is relevant for clinical practice and provide an evidence-based, balanced, patient-oriented review on a focused topic, either clinical or basic science. Because of space limitations, the review is not intended to be exhaustive - it should be directed. These articles should focus on current advancements in the field, and should be based on the latest "cutting-edge" clinical, translational, or basic science. Review Articles should have a structured abstract of no more than 255 words with the following headings: Objective, Data Sources, Study Selections, Results, and Conclusion. A maximum of 12 keywords and 60 references are allowed. Text should not exceed 4,000 words and should be organized into the following sections: Introduction, Methods, Results, Discussion and Conclusion.

 

    Case Studies

Only properly formatted and relevant Case Studies will be considered for publication. Abstracts should be formatted with: Introduction; Case Study; Results; Conclusion. The Main Text should be formatted as: Introduction; Case Study; Results; Discussion; Conclusion.

 

    Letters to the Editor

Letters to the Editor will be considered for publication subject to editor approval and provided that the content relates to articles published in the journal. Letters should be received less than six months after publication of the original work in question. Pending editor approval, letters will be submitted to the author of the original paper in order that a reply can be published simultaneously.

 

     Commentaries

All commentary topics must be checked with the editor prior to submission. Commentaries should be knowledge-based or consensus-type articles (e.g. working group statement) expressing objective opinions, experiences or perspectives on an important area related to asthma.

 

     Book Reviews

Journal of Asthma considers a limited number of book reviews. Book review ideas must be checked with the editor prior to submission.

 

Acknowledgments section

 

Please read the Ethics and Consent below for information about this optional section. In short, the Acknowledgments section details special thanks, personal assistance, and dedications. Acknowledgments should be included in a separate headed section at the end of the manuscript preceding any appendices, and before the Declaration of Interest Section.

 

Declaration of Interest section

 

It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE).

 

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

 

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal’s Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

 

If no conflict is declared, the following statement will be attached to all articles:

 

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

 

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.

 

编委会

 

编辑:        

乔纳森·A·伯恩斯坦,MD  

医学教授

临床研究的主任

辛辛那提大学

内科

俄亥俄州辛辛那提市

 

副主编        

 

戴维·M·兰,MD

医学教授

过敏系主席和临床免疫学

副主任,哮喘中心

主任,过敏免疫学研究员

呼吸研究所

克利夫兰诊所

克利夫兰

 

大学医学博士John M. Weiler,医学博士,

爱荷华大学名誉教授

CompleWare公司总裁

爱荷华市IA

 

 

编辑委员

 

Lara J. AkinbamiMD

国家卫生统计中心,CDC

Hyattsville,马里兰州

 

伊丽莎白D.艾伦,MD

全国儿童医院

俄亥俄州立大学医学院

哥伦布医学院俄亥俄州 

 

金伯利Arcoleo博士,MPH

俄亥俄州立

大学护理学院

哥伦布,俄亥俄州

 

Bengt B. Arnetz,医学博士,MSCEPI

密歇根州立大学密歇根州立大学密歇根

大瀑布城 

 

Don ArnoldMDMPH

范德比尔特大学医学院

田纳西州纳什维尔Koichiro

 

Asano

东京大学医学院医学

神奈川,日本

 

Charles Barnes博士

病理与实验室医学系主任     

     过敏/免疫学实验室

儿童慈善医院     

堪萨斯城,密苏里州    

 

本杰明Joseph BecerraDRPHMBAMPHMS

洛马琳达

大学联合健康专业学校洛马琳达

,加利福尼亚

 

Jocelyn M. 比亚吉尼迈尔斯,

辛辛那提儿童医院医疗中心

辛辛那提,俄亥俄州

 

医学

教授David Bernstein医学教授      

联合主任过敏研究员培训计划    

辛辛那提大学    

辛辛那提,俄亥俄州    

 

Leonard Bielory医学博士

罗伯特伍德约翰逊大学医院    

新不伦瑞克省新泽西州   

 

Mark A. BrownMD

亚利桑那

大学医学院

亚利桑那州图森

 

Scott Burgess博士,FRACP

Mater儿童医院

昆士兰州澳大利亚

 

Arlene ButzSc.D.CRNP

约翰霍普金斯大学

医学院

儿科系

马里兰州

 

巴尔的摩克里斯托弗·卡罗尔医学博士, MS

康涅狄格儿童医学中心

康涅狄格州的哈特福德

 

玛西娅·钱博士

儿童慈善

密苏里州堪萨斯城

 

克里斯托弗·D·科迪斯波蒂博士

拉什大学医学中心的

芝加哥,伊利诺伊州

 

 

斯蒂芬妮坎Deveau -罗森,MD

INOVA的儿童医院

费尔法克斯,弗吉尼亚

 

梅拉妮·迪斯彭萨博士

西北大学

芝加哥,伊利诺伊州

 

克里斯蒂娜邓肯博士

副教授    

临床儿童心理学工程区    

西弗吉尼亚大学    

摩根,西弗吉尼亚州的   


投稿问答最小化  关闭